JBF-16307-77825
3 vaccinations
4 coded responses
25 check-ins
4 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 727 / AR
- Registered
- 2021-03-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-21
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-03
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-13
-
2021-04-13
Pregnancy registry surveyPregnant at time of vaccination · Yes, I would like someone to contact me
-
2021-04-20
Dose 2 — Pfizer-BioNTech
-
2021-04-20
Survey response — 0 day, dose 2MedDRA: Chest discomfort — Feeling: Good · Site: Pain · Fatigue or tirednessMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-27
- 2021-05-04
-
2021-05-11
Survey response — 21 day, dose 2MedDRA: Cough, Oropharyngeal pain, Secretion discharge — Feeling: Good · Be unable to work, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-11
Report sent to call center — 21 day, dose 2Be unable to work · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-20
- 2021-05-27
- 2021-06-01
- 2021-06-04
- 2021-07-20
-
2021-10-19
Survey response — 6 month, dose 2MedDRA: Gastroenteritis viral, Respiratory syncytial virus infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11 · check-in answers available
-
2021-10-19
Report sent to call center — 6 month, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2021-10-20
Call successfulDoes not wish to fill out VAERS report
-
2021-11-08
Dose 3 — ModernaCo-administered: Flu
-
2022-04-22
Survey response — 12 month, dose 2MedDRA: Hypothyroidism — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2022-04-22
Report sent to call center — 12 month, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-04-25
- 2022-05-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech | |
| 3 | 2021-11-08 | Moderna | Flu |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-05-11 | Unsuccessful | |
| 2021-10-19 | Successful 2021-10-20 |
Does not wish to fill out VAERS report |
| 2022-04-22 | Unsuccessful |
Free text
Release 7
Systemic reaction (other): Chest tightness
Release 8
Symptoms: Sore throat, mucus, coughing
Release 10
Symptoms: Rsv, stomach flu
Release 11
Symptoms: Hypothyroidism
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | ✓ | ✓ | ✓ |
| SD | Gastroenteritis viral | · | · | ✓ |
| SD | Hypothyroidism | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Respiratory syncytial virus infection | · | · | ✓ |
| SD | Secretion discharge | ✓ | ✓ | ✓ |
| SRO | Chest discomfort | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release